Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen ... from SARS-CoV-2, the virus responsible ...

In November 2023, the Acon Flowflex COVID-19 Antigen Home Test became the first at-home rapid antigen test cleared ... for use on people as young as 2 years old, provided that any child’s ...

A positive rapid antigen test is more likely to signal the presence of infectious SARS-CoV-2 particles than a positive PCR ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth of plaque in the coronary arteries and an increased risk of cardiovascular ...

The antiviral combination of nirmatrelvir and ritonavir (brand name Paxlovid) is an effective treatment for people with COVID-19 who have mild symptoms and face a high risk of hospitalization. For ...

Omicron has a reputation for causing mild infection compared to delta, but Treasure Coast hospitals still are caring for a ...

Coronary artery lesions in patients with SARS-CoV-2 infection more likely to become high-risk plaques. (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection ...